Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01HZQ
|
|||
| Drug Name |
VP-102
|
|||
| Indication | Molluscum contagiosum infection [ICD-11: 1E76; ICD-10: B08.1] | Phase 3 | [1] | |
| Common wart [ICD-11: 1E80; ICD-10: B07] | Phase 2 | [2] | ||
| Company |
Verrica Pharmaceuticals West Chester, PA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03377803) Cantharidin Application in Molluscum Patients (CAMP-2). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.